Mela Sciences a Leader in the Fight Against Melanoma, to Release Second Quarter 2013 Financial Results and Host Conference Call on Wednesday, August 7, 2013

Published: Jul 18, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

IRVINGTON, N.Y., July 17, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercializing MelaFind®, the first and only FDA approved optical diagnostic device for melanoma detection used by dermatologists in their fight against melanoma, today announced that it will release its 2013 second quarter financial results after the close of trading on Wednesday, August 7, 2013. MELA Sciences' executives will also host a conference call that day at 4:30 PM ET to discuss the results, as well as provide a general business update.

Help employers find you! Check out all the jobs and post your resume.

Back to news